nodes	percent_of_prediction	percent_of_DWPC	metapath
Clavulanate—Induration—Pamidronate—osteoporosis	0.0317	0.0317	CcSEcCtD
Clavulanate—Induration—Zoledronate—osteoporosis	0.0289	0.0289	CcSEcCtD
Clavulanate—Jaundice cholestatic—Estropipate—osteoporosis	0.0215	0.0215	CcSEcCtD
Clavulanate—Thrombophlebitis—Estropipate—osteoporosis	0.0158	0.0158	CcSEcCtD
Clavulanate—Swelling—Ibandronate—osteoporosis	0.0149	0.0149	CcSEcCtD
Clavulanate—Jaundice cholestatic—Conjugated Estrogens—osteoporosis	0.0142	0.0142	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Alendronate—osteoporosis	0.0121	0.0121	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Etidronic acid—osteoporosis	0.0121	0.0121	CcSEcCtD
Clavulanate—Thrombophlebitis—Pamidronate—osteoporosis	0.0119	0.0119	CcSEcCtD
Clavulanate—Swelling—Pamidronate—osteoporosis	0.0117	0.0117	CcSEcCtD
Clavulanate—Jaundice cholestatic—Estradiol—osteoporosis	0.0114	0.0114	CcSEcCtD
Clavulanate—Swelling—Zoledronate—osteoporosis	0.0107	0.0107	CcSEcCtD
Clavulanate—Thrombophlebitis—Conjugated Estrogens—osteoporosis	0.0105	0.0105	CcSEcCtD
Clavulanate—Erythema multiforme—Etidronic acid—osteoporosis	0.0104	0.0104	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Alendronate—osteoporosis	0.0103	0.0103	CcSEcCtD
Clavulanate—Swelling—Conjugated Estrogens—osteoporosis	0.0103	0.0103	CcSEcCtD
Clavulanate—Pain—Calcium Acetate—osteoporosis	0.0101	0.0101	CcSEcCtD
Clavulanate—Haemoglobin—Alendronate—osteoporosis	0.00938	0.00938	CcSEcCtD
Clavulanate—Hypokalaemia—Pamidronate—osteoporosis	0.00936	0.00936	CcSEcCtD
Clavulanate—Haemorrhage—Alendronate—osteoporosis	0.00933	0.00933	CcSEcCtD
Clavulanate—Haemoglobin—Ibandronate—osteoporosis	0.00913	0.00913	CcSEcCtD
Clavulanate—Haemorrhage—Ibandronate—osteoporosis	0.00908	0.00908	CcSEcCtD
Clavulanate—Erythema multiforme—Estropipate—osteoporosis	0.00896	0.00896	CcSEcCtD
Clavulanate—Pain—Ergocalciferol—osteoporosis	0.00895	0.00895	CcSEcCtD
Clavulanate—Haemoglobin—Calcitriol—osteoporosis	0.00894	0.00894	CcSEcCtD
Clavulanate—Haemorrhage—Calcitriol—osteoporosis	0.00889	0.00889	CcSEcCtD
Clavulanate—Erythema multiforme—Alendronate—osteoporosis	0.00882	0.00882	CcSEcCtD
Clavulanate—Hypersensitivity—Calcium Acetate—osteoporosis	0.00873	0.00873	CcSEcCtD
Clavulanate—Hypokalaemia—Zoledronate—osteoporosis	0.00855	0.00855	CcSEcCtD
Clavulanate—Leukopenia—Etidronic acid—osteoporosis	0.00853	0.00853	CcSEcCtD
Clavulanate—Erythema multiforme—Calcitriol—osteoporosis	0.00841	0.00841	CcSEcCtD
Clavulanate—Pruritus—Calcium Acetate—osteoporosis	0.00838	0.00838	CcSEcCtD
Clavulanate—Thrombophlebitis—Estradiol—osteoporosis	0.00836	0.00836	CcSEcCtD
Clavulanate—Hypokalaemia—Conjugated Estrogens—osteoporosis	0.00823	0.00823	CcSEcCtD
Clavulanate—Swelling—Estradiol—osteoporosis	0.00821	0.00821	CcSEcCtD
Clavulanate—Diarrhoea—Calcium Acetate—osteoporosis	0.00811	0.00811	CcSEcCtD
Clavulanate—Haemoglobin—Ethinyl Estradiol—osteoporosis	0.00772	0.00772	CcSEcCtD
Clavulanate—Haemorrhage—Ethinyl Estradiol—osteoporosis	0.00768	0.00768	CcSEcCtD
Clavulanate—Vomiting—Calcium Acetate—osteoporosis	0.00753	0.00753	CcSEcCtD
Clavulanate—Haemoglobin—Risedronate—osteoporosis	0.00752	0.00752	CcSEcCtD
Clavulanate—Haemorrhage—Risedronate—osteoporosis	0.00749	0.00749	CcSEcCtD
Clavulanate—Erythema multiforme—Ethinyl Estradiol—osteoporosis	0.00726	0.00726	CcSEcCtD
Clavulanate—Haemoglobin—Pamidronate—osteoporosis	0.00715	0.00715	CcSEcCtD
Clavulanate—Haemorrhage—Pamidronate—osteoporosis	0.00712	0.00712	CcSEcCtD
Clavulanate—Nausea—Calcium Acetate—osteoporosis	0.00704	0.00704	CcSEcCtD
Clavulanate—Anaphylactic shock—Estropipate—osteoporosis	0.00673	0.00673	CcSEcCtD
Clavulanate—Convulsion—Calcitriol—osteoporosis	0.00671	0.00671	CcSEcCtD
Clavulanate—Anaphylactic shock—Ibandronate—osteoporosis	0.00645	0.00645	CcSEcCtD
Clavulanate—Thrombocytopenia—Raloxifene—osteoporosis	0.00638	0.00638	CcSEcCtD
Clavulanate—Anaphylactic shock—Calcitriol—osteoporosis	0.00632	0.00632	CcSEcCtD
Clavulanate—Nausea—Ergocalciferol—osteoporosis	0.00622	0.00622	CcSEcCtD
Clavulanate—Urticaria—Etidronic acid—osteoporosis	0.00618	0.00618	CcSEcCtD
Clavulanate—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.00592	0.00592	CcSEcCtD
Clavulanate—Pain—Estropipate—osteoporosis	0.00575	0.00575	CcSEcCtD
Clavulanate—Hypersensitivity—Etidronic acid—osteoporosis	0.00573	0.00573	CcSEcCtD
Clavulanate—Pain—Alendronate—osteoporosis	0.00567	0.00567	CcSEcCtD
Clavulanate—Pain—Raloxifene—osteoporosis	0.00557	0.00557	CcSEcCtD
Clavulanate—Leukopenia—Pamidronate—osteoporosis	0.00555	0.00555	CcSEcCtD
Clavulanate—Pain—Ibandronate—osteoporosis	0.00552	0.00552	CcSEcCtD
Clavulanate—Pruritus—Etidronic acid—osteoporosis	0.0055	0.0055	CcSEcCtD
Clavulanate—Pain—Calcitriol—osteoporosis	0.0054	0.0054	CcSEcCtD
Clavulanate—Convulsion—Pamidronate—osteoporosis	0.00537	0.00537	CcSEcCtD
Clavulanate—Urticaria—Estropipate—osteoporosis	0.00535	0.00535	CcSEcCtD
Clavulanate—Diarrhoea—Etidronic acid—osteoporosis	0.00532	0.00532	CcSEcCtD
Clavulanate—Urticaria—Alendronate—osteoporosis	0.00527	0.00527	CcSEcCtD
Clavulanate—Urticaria—Ibandronate—osteoporosis	0.00513	0.00513	CcSEcCtD
Clavulanate—Leukopenia—Zoledronate—osteoporosis	0.00507	0.00507	CcSEcCtD
Clavulanate—Anaphylactic shock—Pamidronate—osteoporosis	0.00506	0.00506	CcSEcCtD
Clavulanate—Haemoglobin—Estradiol—osteoporosis	0.00503	0.00503	CcSEcCtD
Clavulanate—Urticaria—Calcitriol—osteoporosis	0.00502	0.00502	CcSEcCtD
Clavulanate—Hepatitis—Estradiol—osteoporosis	0.00501	0.00501	CcSEcCtD
Clavulanate—Haemorrhage—Estradiol—osteoporosis	0.00501	0.00501	CcSEcCtD
Clavulanate—Hypersensitivity—Estropipate—osteoporosis	0.00496	0.00496	CcSEcCtD
Clavulanate—Thrombocytopenia—Pamidronate—osteoporosis	0.00495	0.00495	CcSEcCtD
Clavulanate—Vomiting—Etidronic acid—osteoporosis	0.00495	0.00495	CcSEcCtD
Clavulanate—Rash—Etidronic acid—osteoporosis	0.0049	0.0049	CcSEcCtD
Clavulanate—Convulsion—Zoledronate—osteoporosis	0.0049	0.0049	CcSEcCtD
Clavulanate—Dermatitis—Etidronic acid—osteoporosis	0.0049	0.0049	CcSEcCtD
Clavulanate—Hypersensitivity—Alendronate—osteoporosis	0.00488	0.00488	CcSEcCtD
Clavulanate—Pruritus—Estropipate—osteoporosis	0.00476	0.00476	CcSEcCtD
Clavulanate—Hypersensitivity—Ibandronate—osteoporosis	0.00475	0.00475	CcSEcCtD
Clavulanate—Erythema multiforme—Estradiol—osteoporosis	0.00474	0.00474	CcSEcCtD
Clavulanate—Convulsion—Conjugated Estrogens—osteoporosis	0.00472	0.00472	CcSEcCtD
Clavulanate—Pruritus—Alendronate—osteoporosis	0.00469	0.00469	CcSEcCtD
Clavulanate—Hypersensitivity—Calcitriol—osteoporosis	0.00465	0.00465	CcSEcCtD
Clavulanate—Nausea—Etidronic acid—osteoporosis	0.00462	0.00462	CcSEcCtD
Clavulanate—Anaphylactic shock—Zoledronate—osteoporosis	0.00462	0.00462	CcSEcCtD
Clavulanate—Diarrhoea—Estropipate—osteoporosis	0.0046	0.0046	CcSEcCtD
Clavulanate—Pruritus—Ibandronate—osteoporosis	0.00457	0.00457	CcSEcCtD
Clavulanate—Pain—Risedronate—osteoporosis	0.00455	0.00455	CcSEcCtD
Clavulanate—Diarrhoea—Alendronate—osteoporosis	0.00454	0.00454	CcSEcCtD
Clavulanate—Thrombocytopenia—Zoledronate—osteoporosis	0.00452	0.00452	CcSEcCtD
Clavulanate—Pruritus—Calcitriol—osteoporosis	0.00447	0.00447	CcSEcCtD
Clavulanate—Diarrhoea—Raloxifene—osteoporosis	0.00446	0.00446	CcSEcCtD
Clavulanate—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00445	0.00445	CcSEcCtD
Clavulanate—Diarrhoea—Ibandronate—osteoporosis	0.00442	0.00442	CcSEcCtD
Clavulanate—Urticaria—Ethinyl Estradiol—osteoporosis	0.00433	0.00433	CcSEcCtD
Clavulanate—Pain—Pamidronate—osteoporosis	0.00432	0.00432	CcSEcCtD
Clavulanate—Diarrhoea—Calcitriol—osteoporosis	0.00432	0.00432	CcSEcCtD
Clavulanate—Vomiting—Estropipate—osteoporosis	0.00428	0.00428	CcSEcCtD
Clavulanate—Rash—Estropipate—osteoporosis	0.00424	0.00424	CcSEcCtD
Clavulanate—Dermatitis—Estropipate—osteoporosis	0.00424	0.00424	CcSEcCtD
Clavulanate—Urticaria—Risedronate—osteoporosis	0.00423	0.00423	CcSEcCtD
Clavulanate—Vomiting—Alendronate—osteoporosis	0.00421	0.00421	CcSEcCtD
Clavulanate—Rash—Alendronate—osteoporosis	0.00418	0.00418	CcSEcCtD
Clavulanate—Dermatitis—Alendronate—osteoporosis	0.00418	0.00418	CcSEcCtD
Clavulanate—Vomiting—Raloxifene—osteoporosis	0.00414	0.00414	CcSEcCtD
Clavulanate—Rash—Raloxifene—osteoporosis	0.00411	0.00411	CcSEcCtD
Clavulanate—Dermatitis—Raloxifene—osteoporosis	0.00411	0.00411	CcSEcCtD
Clavulanate—Vomiting—Ibandronate—osteoporosis	0.0041	0.0041	CcSEcCtD
Clavulanate—Rash—Ibandronate—osteoporosis	0.00407	0.00407	CcSEcCtD
Clavulanate—Dermatitis—Ibandronate—osteoporosis	0.00407	0.00407	CcSEcCtD
Clavulanate—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00402	0.00402	CcSEcCtD
Clavulanate—Vomiting—Calcitriol—osteoporosis	0.00402	0.00402	CcSEcCtD
Clavulanate—Nausea—Estropipate—osteoporosis	0.004	0.004	CcSEcCtD
Clavulanate—Rash—Calcitriol—osteoporosis	0.00398	0.00398	CcSEcCtD
Clavulanate—Dermatitis—Calcitriol—osteoporosis	0.00398	0.00398	CcSEcCtD
Clavulanate—Pain—Zoledronate—osteoporosis	0.00395	0.00395	CcSEcCtD
Clavulanate—Nausea—Alendronate—osteoporosis	0.00394	0.00394	CcSEcCtD
Clavulanate—Hypersensitivity—Risedronate—osteoporosis	0.00392	0.00392	CcSEcCtD
Clavulanate—Nausea—Raloxifene—osteoporosis	0.00387	0.00387	CcSEcCtD
Clavulanate—Pruritus—Ethinyl Estradiol—osteoporosis	0.00386	0.00386	CcSEcCtD
Clavulanate—Nausea—Ibandronate—osteoporosis	0.00383	0.00383	CcSEcCtD
Clavulanate—Pain—Conjugated Estrogens—osteoporosis	0.0038	0.0038	CcSEcCtD
Clavulanate—Pruritus—Risedronate—osteoporosis	0.00376	0.00376	CcSEcCtD
Clavulanate—Nausea—Calcitriol—osteoporosis	0.00375	0.00375	CcSEcCtD
Clavulanate—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00373	0.00373	CcSEcCtD
Clavulanate—Hypersensitivity—Pamidronate—osteoporosis	0.00372	0.00372	CcSEcCtD
Clavulanate—Urticaria—Zoledronate—osteoporosis	0.00367	0.00367	CcSEcCtD
Clavulanate—Diarrhoea—Risedronate—osteoporosis	0.00364	0.00364	CcSEcCtD
Clavulanate—Pruritus—Pamidronate—osteoporosis	0.00358	0.00358	CcSEcCtD
Clavulanate—Anaphylactic shock—Estradiol—osteoporosis	0.00356	0.00356	CcSEcCtD
Clavulanate—Urticaria—Conjugated Estrogens—osteoporosis	0.00353	0.00353	CcSEcCtD
Clavulanate—Vomiting—Ethinyl Estradiol—osteoporosis	0.00347	0.00347	CcSEcCtD
Clavulanate—Diarrhoea—Pamidronate—osteoporosis	0.00346	0.00346	CcSEcCtD
Clavulanate—Rash—Ethinyl Estradiol—osteoporosis	0.00344	0.00344	CcSEcCtD
Clavulanate—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00344	0.00344	CcSEcCtD
Clavulanate—Hypersensitivity—Zoledronate—osteoporosis	0.0034	0.0034	CcSEcCtD
Clavulanate—Vomiting—Risedronate—osteoporosis	0.00338	0.00338	CcSEcCtD
Clavulanate—Rash—Risedronate—osteoporosis	0.00335	0.00335	CcSEcCtD
Clavulanate—Dermatitis—Risedronate—osteoporosis	0.00335	0.00335	CcSEcCtD
Clavulanate—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00328	0.00328	CcSEcCtD
Clavulanate—Pruritus—Zoledronate—osteoporosis	0.00327	0.00327	CcSEcCtD
Clavulanate—Nausea—Ethinyl Estradiol—osteoporosis	0.00324	0.00324	CcSEcCtD
Clavulanate—Vomiting—Pamidronate—osteoporosis	0.00321	0.00321	CcSEcCtD
Clavulanate—Rash—Pamidronate—osteoporosis	0.00319	0.00319	CcSEcCtD
Clavulanate—Dermatitis—Pamidronate—osteoporosis	0.00318	0.00318	CcSEcCtD
Clavulanate—Diarrhoea—Zoledronate—osteoporosis	0.00316	0.00316	CcSEcCtD
Clavulanate—Nausea—Risedronate—osteoporosis	0.00316	0.00316	CcSEcCtD
Clavulanate—Pruritus—Conjugated Estrogens—osteoporosis	0.00315	0.00315	CcSEcCtD
Clavulanate—Pain—Estradiol—osteoporosis	0.00304	0.00304	CcSEcCtD
Clavulanate—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00304	0.00304	CcSEcCtD
Clavulanate—Nausea—Pamidronate—osteoporosis	0.003	0.003	CcSEcCtD
Clavulanate—Vomiting—Zoledronate—osteoporosis	0.00294	0.00294	CcSEcCtD
Clavulanate—Rash—Zoledronate—osteoporosis	0.00291	0.00291	CcSEcCtD
Clavulanate—Dermatitis—Zoledronate—osteoporosis	0.00291	0.00291	CcSEcCtD
Clavulanate—Vomiting—Conjugated Estrogens—osteoporosis	0.00283	0.00283	CcSEcCtD
Clavulanate—Urticaria—Estradiol—osteoporosis	0.00283	0.00283	CcSEcCtD
Clavulanate—Rash—Conjugated Estrogens—osteoporosis	0.0028	0.0028	CcSEcCtD
Clavulanate—Dermatitis—Conjugated Estrogens—osteoporosis	0.0028	0.0028	CcSEcCtD
Clavulanate—Nausea—Zoledronate—osteoporosis	0.00274	0.00274	CcSEcCtD
Clavulanate—Nausea—Conjugated Estrogens—osteoporosis	0.00264	0.00264	CcSEcCtD
Clavulanate—Hypersensitivity—Estradiol—osteoporosis	0.00262	0.00262	CcSEcCtD
Clavulanate—Pruritus—Estradiol—osteoporosis	0.00252	0.00252	CcSEcCtD
Clavulanate—Diarrhoea—Estradiol—osteoporosis	0.00244	0.00244	CcSEcCtD
Clavulanate—Vomiting—Estradiol—osteoporosis	0.00226	0.00226	CcSEcCtD
Clavulanate—Rash—Estradiol—osteoporosis	0.00224	0.00224	CcSEcCtD
Clavulanate—Dermatitis—Estradiol—osteoporosis	0.00224	0.00224	CcSEcCtD
Clavulanate—Nausea—Estradiol—osteoporosis	0.00211	0.00211	CcSEcCtD
